Cutaneous T-cell lymphoma with CNS involvement: a case series and review of the literature

References

• DummerR, VermeerMH, ScarisbrickJJet al. Cutaneous T cell lymphoma. Nat. Rev. Dis. Primers7(1), 61 (2021).
   PubMed Web of Science ®Google Scholar
• WillemzeR, HodakE, ZinzaniPL, SpechtL, LadettoM. Primary cutaneous lymphomas: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann. Oncol.29, iv30–iv40 (2018).
   PubMed Web of Science ®Google Scholar
• BagheraniN, SmollerBR. An overview of cutaneous T cell lymphomas. F1000Res5, 1882 (2016).
   Google Scholar
• KimYH, LiuHL, Mraz-GernhardS, VargheseA, HoppeRT. Long-term outcome of 525 patients with mycosis fungoides and Sézary syndrome: clinical prognostic factors and risk for disease progression. Arch. Dermatol.139(7), 857–866 (2003).
   PubMedGoogle Scholar
• AgarNS, WedgeworthE, CrichtonSet al. Survival outcomes and prognostic factors in mycosis fungoides/Sézary Syndrome: validation of the Revised International Society for Cutaneous Lymphomas/European Organisation for Research and Treatment of Cancer Staging Proposal. J. Clin. Oncol.28(31), 4730–4739 (2010).
   PubMed Web of Science ®Google Scholar
• KempfW, MitteldorfC. Cutaneous T-cell lymphomas – an update 2021. Hematol. Oncol.39(Suppl. 1), 46–51 (2021).
   PubMedGoogle Scholar
• PulitzerM. Cutaneous T-cell lymphoma. Clin. Lab. Med.37(3), 527–546 (2017).
   PubMed Web of Science ®Google Scholar
• ZhaoG, ChamberlainMC, KhotSP, ShustovA, OlerudJE, ShinoharaMM. Central nervous system involvement in cutaneous T-cell lymphoma: 2 illustrative cases and a review of current literature. Clin. Lymph. Myel. Leuk.14(1), e25–e30 (2014).
   PubMedGoogle Scholar
• YangY, WicklessH. Thinking about CNS metastasis in cutaneous lymphoma: analysis of existing data. Leukemia Res. Reports8, 14–18 (2017).
   PubMedGoogle Scholar
• HristovAC, TejasviT, AWilcox R. Wilcox R. Cutaneous T-cell lymphomas: 2021 update on diagnosis, risk-stratification, and management. American J. Hematol.96(10), 1313–1328 (2021).
   PubMed Web of Science ®Google Scholar
• ZhuangTZ, McCook-VealA, SwitchenkoJet al. Characterizing outcomes in visceral cutaneous T-cell lymphoma: a single center retrospective study. Clin. Lymphoma Myel. Leukemia23(9), 667–673 (2023).
   PubMed Web of Science ®Google Scholar
• JensenGL, DabajaBS, PinnixCCet al. Radiotherapy in patients with mycosis fungoides and central nervous system involvement. Case Rep. Oncol.11(3), 721–728 (2018).
   PubMedGoogle Scholar
• VuBA, DuvicM. Central nervous system involvement in patients with mycosis fungoides and cutaneous large-cell transformation. J. Am. Acad. Dermatol.59(2), S16–S22 (2008).
   PubMed Web of Science ®Google Scholar
• ChuaSL, SeymourJF, PrinceHM. Deafness from eighth cranial nerve involvement in a patient with large-cell transformation of mycosis fungoides. Eur. J. Haematol.64(5), 340–343 (2000).
   PubMed Web of Science ®Google Scholar
• HarringtonL, SokolL, HoldenerS, ShaoH, ZhangL. Cutaneous gamma-delta T-cell lymphoma with central nervous system involvement: report of a rarity with review of literature. J. Cutan. Pathol.41(12), 936–943 (2014).
   PubMed Web of Science ®Google Scholar
• SteinM, FarrarN, JonesGWet al. Central neurologic involvement in mycosis fungoides: ten cases, actuarial risk assessment, and predictive factors. Cancer J.12(1), 55–62 (2006).
   PubMed Web of Science ®Google Scholar
• DoerschnerM, Pekar-LukacsA, Messerli-OdermattOet al. Interferon alfa-2a maintenance after salvage autologous stem cell transplantation in atypical mycosis fungoides with central nervous system involvement. Br. J. Dermatol.181(6), 1296–1302 (2019).
   PubMed Web of Science ®Google Scholar
• LindaeML, LuyJ, AbelEA, KaplanR. Mycosis fungoides with CNS involvement: neuropsychiatric manifestations and complications of treatment with intrathecal methotrexate and whole-brain irradiation. J. Dermatol. Surg. Oncol.16(6), 550–553 (1990).
   PubMedGoogle Scholar
• NayakS, DrappatzJ. Successful treatment of CNS involvement in cutaneous T-cell lymphoma mycosis fungoides (P2.6-009). Neurology92(Suppl. 15), (2019).
   Web of Science ®Google Scholar
• WylenE, WilliamsB, NandaA. Cutaneous T-cell lymphoma with intracerebral and bilateral intraocular spread. Neurol. Res.20(4), 307–312 (1998).
   PubMed Web of Science ®Google Scholar
• BodensteinerDC, SkikneB. Central nervous system involvement in mycosis fungoides: diagnosis, treatment and literature review. Cancer50(6), 1181–1184 (1982).
   PubMed Web of Science ®Google Scholar
• GiorliE, TraversoE, BenedettiLet al. Central nervous system involvement in mycosis fungoides: relevance of TCR gene testing in cerebrospinal fluid. Springerplus3, 29 (2014).
   PubMedGoogle Scholar
• GrevelinkSA, FullerGN, OlsenEA. Central nervous system involvement by cutaneous T cell lymphoma. J. Am. Acad. Dermatol.25(3), 542–549 (1991).
   PubMed Web of Science ®Google Scholar
• NguyenGH, MohlerA, LeppertMet al. Index case of cutaneous follicular mycosis fungoides with central nervous system involvement and review of literature. Am. J. Dermatopathol.40(3), 185–190 (2018).
   PubMed Web of Science ®Google Scholar
• HauchTW, ShelbourneJD, CohenHJ, MasonD, KremerWB. Meningeal mycosis fungoides: clinical and cellular characteristics. Ann. Intern. Med.82(4), 499–505 (1975).
   PubMed Web of Science ®Google Scholar
• HarrisPA, TaylorR, MinorBLet al. The REDCap consortium: building an international community of software platform partners. J. Biomed. Informatics95, DOI: 10.1016/j.jbi.2019.103208 (2019).
   PubMed Web of Science ®Google Scholar
• HarrisPA, TaylorR, ThielkeR, PayneJ, GonzalezN, CondeJG. Research electronic data capture (REDCap) – a metadata-driven methodology and workflow process for providing translational research informatics support. J. Biomed. Informatics42(2), 377–381 (2009).
   PubMed Web of Science ®Google Scholar
• CalimeriT, SteffanoniS, GagliardiF, ChiaraA, FerreriAJM. How we treat primary central nervous system lymphoma. ESMO Open6(4), DOI: 10.1016/j.esmoop.2021.100213 (2021).
   Web of Science ®Google Scholar
• GrommesC, DeAngelisLM. Primary CNS lymphoma. J. Clin. Oncol.35(21), 2410–2418 (2017).
   PubMed Web of Science ®Google Scholar
• QuaglinoP, MauleM, PrinceHMet al. Global patterns of care in advanced stage mycosis fungoides/Sezary syndrome: a multicenter retrospective follow-up study from the Cutaneous Lymphoma International Consortium. Ann. Oncol.28(10), 2517–2525 (2017).
   PubMed Web of Science ®Google Scholar
• HorwitzSM, ScarisbrickJJ, DummerRet al. Randomized phase 3 ALCANZA study of brentuximab vedotin vs physician’s choice in cutaneous T-cell lymphoma: final data. Blood Advances5(23), 5098–5106 (2021).
   PubMed Web of Science ®Google Scholar
• KimYH, BagotM, Pinter-BrownLet al. Mogamulizumab versus vorinostat in previously treated cutaneous T-cell lymphoma (MAVORIC): an international, open-label, randomised, controlled phase 3 trial. Lancet Oncol.19(9), 1192–1204 (2018).
   PubMed Web of Science ®Google Scholar
• OguraM, IshidaT, HatakeKet al. Multicenter Phase II study of mogamulizumab (KW-0761), a defucosylated Anti-CC chemokine receptor 4 antibody, in patients with relapsed peripheral T-cell lymphoma and cutaneous T-cell lymphoma. J. Clin. Oncol.32(11), 1157–1163 (2014).
   PubMed Web of Science ®Google Scholar
• DuvicM, Pinter-BrownLC, FossFMet al. Phase I/II study of mogamulizumab, a defucosylated anti-CCR4 antibody, in previously treated patients with cutaneous T-cell lymphoma. Blood125(12), 1883–1889 (2015).
   PubMed Web of Science ®Google Scholar
• Kyowa Hakko Kirin Pharma, Inc. Open-label, multi-center, dose escalation Phase 1/2 study of anti-CCR4 monoclonal antibody KW-0761 as monotherapy in subjects with previously treated peripheral T-cell lymphoma. clinicaltrials.gov (2020).
   Google Scholar
• Kyowa Kirin, Inc. Open-label, multi-center, randomized study of anti-CCR4 monoclonal antibody KW-0761 (mogamulizumab) versus vorinostat in subjects with previously treated cutaneous T-cell lymphoma. clinicaltrials.gov (2022).
   Google Scholar
• DelacruzW, SetlikR, HassantoufighiAet al. Novel brentuximab vedotin combination therapies show promising activity in highly refractory CD30+ Non-Hodgkin lymphoma: a case series and review of the literature. Case Rep. Oncol. Med.2016, 1–7 (2016).
   Google Scholar
• MocikováH, MalikovaH, HolestaM, ElturkiA, CamprV, KozakT. Durable response to brentuximab vedotin-based chemotherapy in refractory Hodgkin lymphoma with central nervous system (CNS) involvement. Am. J. Case Rep.21, e921657 (2020).
   PubMed Web of Science ®Google Scholar
• KimY, SudoA, OyamaRet al. Isolated central nervous system progression during systemic treatment with brentuximab vedotin monotherapy in a pediatric patient with recurrent ALK-negative anaplastic large cell lymphoma. J. Pediatr. Hematol. Oncol.43(6), e864–e866 (2021).
   PubMed Web of Science ®Google Scholar
• AbidMB, WangS, LoiHY, PoonLM. ALK-negative anaplastic large cell lymphoma with CNS involvement needs more than just brentuximab vedotin. Ann. Hematol.95(10), 1725–1726 (2016).
   PubMed Web of Science ®Google Scholar
• TashimaT. Brain cancer chemotherapy through a delivery system across the blood-brain barrier into the brain based on receptor-mediated transcytosis using monoclonal antibody conjugates. Biomedicines10(7), (2022).
   PubMed Web of Science ®Google Scholar
• AllenP, CaseK, ZhuangTet al. Transformed mycosis fungoides: clinical and pathologic characteristics in a single center retrospective analysis. Blood138(Suppl. 1), 2446–2446 (2021).
   PubMedGoogle Scholar
• AllenP, McCookAA, SwitchenkoJM, VarmaS, LechowiczMJ, TarabadkarES. Risk factors for progression from early to advanced stage mycosis fungoides: a single center retrospective analysis at the Winship Cancer Institute of Emory University. Blood138(Suppl. 1), 1378 (2021).
   PubMedGoogle Scholar
• KhetanV. Diffuse infiltrating retinoblastoma with central nervous system metastasis. Arch. Ophthalmol.129(3), 373 (2011).
   PubMedGoogle Scholar
• GrimmSA, McCannelCA, OmuroAMPet al. Primary CNS lymphoma with intraocular involvement: International PCNSL Collaborative Group Report. Neurology71(17), 1355–1360 (2008).
   PubMed Web of Science ®Google Scholar
• GrisoldW, GrisoldA. Cancer around the brain. Neurooncol. Prac.1(1), 13–21 (2014).
   PubMedGoogle Scholar